Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1998 1
1999 1
2001 1
2006 1
2009 1
2010 1
2011 1
2012 1
2015 2
2017 2
2018 2
2019 4
2020 5
2021 10
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Feld JJ, Kandel C, Biondi MJ, Kozak RA, Zahoor MA, Lemieux C, Borgia SM, Boggild AK, Powis J, McCready J, Tan DHS, Chan T, Coburn B, Kumar D, Humar A, Chan A, O'Neil B, Noureldin S, Booth J, Hong R, Smookler D, Aleyadeh W, Patel A, Barber B, Casey J, Hiebert R, Mistry H, Choong I, Hislop C, Santer DM, Lorne Tyrrell D, Glenn JS, Gehring AJ, Janssen HLA, Hansen BE. Feld JJ, et al. Among authors: borgia sm. Lancet Respir Med. 2021 May;9(5):498-510. doi: 10.1016/S2213-2600(20)30566-X. Epub 2021 Feb 5. Lancet Respir Med. 2021. PMID: 33556319 Free PMC article. Clinical Trial.
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial.
Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, Costiniuk C, Daley P, Daneman N, Douglas J, Downey C, Duan E, Duceppe E, Durand M, English S, Farjou G, Fera E, Fontela P, Fowler R, Fralick M, Geagea A, Grant J, Harrison LB, Havey T, Hoang H, Kelly LE, Keynan Y, Khwaja K, Klein G, Klein M, Kolan C, Kronfli N, Lamontagne F, Lau R, Fralick M, Lee TC, Lee N, Lim R, Longo S, Lostun A, MacIntyre E, Malhamé I, Mangof K, McGuinty M, Mergler S, Munan MP, Murthy S, O'Neil C, Ovakim D, Papenburg J, Parhar K, Parvathy SN, Patel C, Perez-Patrigeon S, Pinto R, Rajakumaran S, Rishu A, Roba-Oshin M, Rushton M, Saleem M, Salvadori M, Scherr K, Schwartz K, Semret M, Silverman M, Singh A, Sligl W, Smith S, Somayaji R, Tan DHS, Tobin S, Todd M, Tran TV, Tremblay A, Tsang J, Turgeon A, Vakil E, Weatherald J, Yansouni C, Zarychanski R; Canadian Treatments for COVID-19 (CATCO); Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care Trials Group. Ali K, et al. Among authors: borgia s. CMAJ. 2022 Feb 22;194(7):E242-E251. doi: 10.1503/cmaj.211698. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045989 Free PMC article. Clinical Trial.
Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, Canada.
Jamal AJ, Mataseje LF, Brown KA, Katz K, Johnstone J, Muller MP, Allen VG, Borgia S, Boyd DA, Ciccotelli W, Delibasic K, Fisman DN, Khan N, Leis JA, Li AX, Mehta M, Ng W, Pantelidis R, Paterson A, Pikula G, Sawicki R, Schmidt S, Souto R, Tang L, Thomas C, McGeer AJ, Mulvey MR. Jamal AJ, et al. Among authors: borgia s. J Hosp Infect. 2020 Dec;106(4):820-827. doi: 10.1016/j.jhin.2020.09.007. Epub 2020 Sep 9. J Hosp Infect. 2020. PMID: 32916210
Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1.
Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN). Kohler PP, et al. Among authors: borgia s. Emerg Infect Dis. 2018 Sep;24(9):1674-1682. doi: 10.3201/eid2409.180164. Emerg Infect Dis. 2018. PMID: 30124197 Free PMC article.
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry.
Zhanel GG, Kosar J, Baxter M, Dhami R, Borgia S, Irfan N, MacDonald KS, Dow G, Lagacé-Wiens P, Dube M, Bergevin M, Tascini C, Keynan Y, Walkty A, Karlowsky J. Zhanel GG, et al. Among authors: borgia s. J Glob Antimicrob Resist. 2021 Mar;24:335-339. doi: 10.1016/j.jgar.2021.01.014. Epub 2021 Feb 1. J Glob Antimicrob Resist. 2021. PMID: 33540083 Free article.
Standard versus combined chemical, mechanical, and heat decontamination of hospital drains harboring carbapenemase-producing organisms (CPOs): A randomized controlled trial.
Jamal AJ, Pantelidis R, Sawicki R, Li AX, Chiu W, Morrison D, Marshman J, Baqi M, Richardson D, McGeer AJ, Borgia S. Jamal AJ, et al. Among authors: borgia s. Infect Control Hosp Epidemiol. 2021 Oct;42(10):1275-1278. doi: 10.1017/ice.2020.1384. Epub 2021 Feb 8. Infect Control Hosp Epidemiol. 2021. PMID: 33551004
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.
Zhanel GG, Dhami R, Baxter M, Kosar J, Cervera C, Irfan N, Zvonar R, Borgia S, Tessier JF, Dow G, Ariano R, Dube M, Savoie M, Bassetti M, Walkty A, Karlowsky JA. Zhanel GG, et al. Among authors: borgia s. J Glob Antimicrob Resist. 2021 Jun;25:346-350. doi: 10.1016/j.jgar.2021.03.025. Epub 2021 May 11. J Glob Antimicrob Resist. 2021. PMID: 33984530 Free article.
35 results